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Abstract
Hypercholesterolemia is common in older adults and less treated, but little is known about
correlates of untreated hypercholesterolemia. Using a standard interview method we exam-
ined a random sample of 7,572 participants aged60 years in a community-based house-
hold survey across 7 provinces of China during 2007–2012, and documented 328 cases of
hypercholesterolemia from self-reported doctor diagnosis. Compared to participants with
normal cholesterol, older adults with hypercholesterolemia had higher socioeconomic posi-
tion and larger body mass index. In patients with hypercholesterolemia, 209 were not
treated using lipid-lowering medications (63.7%, 95% confidence interval (CI) 58.5%–
68.9%). Untreated hypercholesterolemia was significantly associated with female sex
(adjusted odds ratio 2.13, 95%CI 1.17–3.89), current smoking (3.48, 1.44–8.44), heavy
alcohol drinking (3.13,1.11–8.84), chronic bronchitis (2.37,1.14–4.90) and high level of
meat consumptions (2.85,1.22–6.65). Although having coronary heart disease exposed
participants for treatment, half of participants with coronary heart disease did not receive
lipid-lowering medications. Among hypercholesterolemia participants with stroke, hyperten-
sion or diabetes, more than half of them did not receive lipid-lowering medications. The high
proportion of untreated hypercholesterolemia in older, high-risk Chinese adults needs to be
mitigated through multi-faceted primary and secondary prevention strategies to increase
population opportunities of treating hypercholesterolemia.
PLOS ONE | DOI:10.1371/journal.pone.0131318 July 10, 2015 1 / 13
OPEN ACCESS
Citation: Hu Z, Zaman MJ, Wang J, Peacock JL,
Chen R (2015) Correlates of Untreated
Hypercholesterolemia in Older Adults: A Community-
Based Household Survey in China. PLoS ONE 10(7):
e0131318. doi:10.1371/journal.pone.0131318
Editor: Giuseppe Schillaci, University of Perugia,
ITALY
Received: October 24, 2014
Accepted: June 1, 2015
Published: July 10, 2015
Copyright: © 2015 Hu et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: The data collection of this study was
funded by research grants from the BUPA Foundation
(Grants Nos. 45NOV06, and TBF-M09-05), the
Alzheimer’s Research UK (Grants Nos. ART/
PPG2007B/2) and Anhui Province Natural Science
Fund, China. The sponsors of the study had no role
in study design, data analysis, data interpretation or
writing of the report. The opinions expressed in this
report are not necessarily those of the funders.
Introduction
Hypercholesterolemia is a major risk factor for cardiovascular disease. Clinical trials have
repeatedly demonstrated that lipid-lowering medication, mainly in the form of statins, reduces
future cardiovascular events. [1,2] This treatment effect is also true for older adults. [3] Serial
health surveys conducted in European populations have documented a significant increase in
the use of lipid-lowering medication in the general populations over time.[4,5] However, a sub-
stantial proportion of people with hypercholesterolemia remain untreated. [6,7] The reason
remains unclear. Previous studies have shown that not receiving lipid-lowering medication for
primary prevention is associated with younger age, male sex and smoking, [8] while for sec-
ondary prevention it is associated with older age and female sex. [9] These studies focused on
young and middle aged populations, and the correlates of untreated hypercholesterolemia in
older adults have not been well investigated.[10]
Current knowledge about the management of lipid lowering medication in people with
hypercholesterolemia is predominately derived from studies undertaken in high-income coun-
tries, [7] [8] [9] thus limiting translation of findings to low and middle- income countries
(LMICs) across the world. In LMICs, the number of people with hypercholesterolemia has
increased over the last three decades, as countries undergo epidemiological transition. [11,12]
Studying a population in LMICs may offer internationally applicable insights into the propor-
tion and correlates of untreated hypercholesterolemia. China is the biggest among the LIMCs,
and the world’s most populous nation. Since the economic reform of the 1980s, China has had
a rapid growth in income and increase in life expectancy. The number of older people in
China, defined age of> = 60 years, [13] has increased in the past 3 decades. There is concomi-
tantly an increasing prevalence of hypercholesterolemia in the Chinese population,[14] ensuing
coronary heart disease and stroke.[6] In this paper we examine data from a community-dwell-
ing based study of older adults in China [15] to identify proportion and correlates of untreated
hypercholesterolemia.
Methods
The data were derived from a large-scale cross-sectional study in 2007–2011 across 7 provinces
in China for this study. [15, 16]
Study populations
We included all participants in a four-province study, the Hubei province study and the Anhui
province cohort 3rd wave study [15], and also Xinjiang Uyghur Autonomous Region study
(rural areas) [16]. These studies were community-based household surveys, with a common
research protocol which is derived from that in the four-province study [15]. Recruiting partic-
ipants and collecting data were carried out in 2007–2011. The Four-Province Study: The sam-
pling methods of the four-province study population have been fully described before. [15] In
brief, we selected one rural and one urban community from each of four provinces (Guang-
dong, Heilongjiang, Shanghai and Shanxi–four research centres) as the study fields, aiming to
recruit more than 500 participants in each community. We employed a cluster randomised
sampling method to choose residential communities from each of the four provinces. The tar-
get population consisted of residents aged60 years living in the area for at least five years.
Ethical approval for the study was obtained from the Research Ethics Committee, University
College London, UK, and from the Research Ethics Committee of Anhui Medical University
and the local governments in China. Based on the residency list of the committees of the village
and the district, we recruited a total of 4,314 participants with an overall response rate of
93.8%. The Hubei and Xinjiang studies: we extended the project to include in Hubei province
Correlates of Untreated Hypercholesterolemia in Older Adults
PLOS ONE | DOI:10.1371/journal.pone.0131318 July 10, 2015 2 / 13
Competing Interests: The authors have declared
that no competing interests exist.
and the Xinjiang Uyghur Autonomous Region, using the same protocol as in the four-province
study. In Hubei, we selected one urban and one rural areas to recruited 1,001 participants
aged 60 years, and achieved a response rate of 91.8%. [15] In Xinjiang Uyghur Autonomous
Region, we interviewed 500 participants in rural areas in Urumqi County, Lop county and
Hami back to the urban and rural for this study, with a response rate of 91.3%. [16] The Anhui
province cohort study—third wave survey: the methods of the Anhui cohort study has been
fully described in previous publications.[15] In brief, in 2001–2003 we interviewed a random
sample of 3,336 residents aged 60 years in urban and rural of Anhui province for mental
health in older Chinese (wave 1). One year after the baseline investigation we re-examined
2,608 cohort members (wave 2). In 2007–2009 we successfully interviewed 1,757 survivors
(wave 3), with a response rate of 82.4% of surviving cohort members.
Interview and data collection
Two researchers from each centre (province) team were trained at the Anhui Medical Univer-
sity, where we had previously completed several surveys of mental illness in older people and
had an experienced interview team.[17] The trained researchers cascaded skills to local
research teams and trained the interviewers. The local survey teams from Anhui, Guangzhou
(Guangdong), Harbin (Heilongjiang), Shanxi and Hubei Medical Universities, School of Public
Health of Fudan University (Shanghai), and The People's Hospital of Xinjiang Uyghur autono-
mous region interviewed the participants at home. Permission for interview and written
informed consent were obtained from each participant or if that was not possible, from the
closest responsible adult. Refusals were respected. In about 5% of the interviews, informed con-
sent was impossible to elicit; in these cases, the nearest relative or carer was approached to pro-
vide assent to participation. The main interview included a general health and risk factors
record,[17] the Geriatric Mental State (GMS) questionnaire,[18] and other components of the
10/66 algorithm dementia research package.[19]
In the general health and risk factors component we recorded details relating to socio-
demography, social networks and support, and cardiovascular (CVD) and risk factors. Socio-
economic variables included rural/urban domicile area, educational level, occupational class,
and annual personal and family incomes. Information about hobbies, physical activity and
Daily Life Activity were documented. We asked participants (or their carers if the participant
was unable to answer) if they had received a doctor’s diagnosis of heart disease (1.coronary
heart disease–CHD, 2. valve disease, or 3. others), angina, stroke, diabetes, chronic bronchitis,
chronic kidney disease, cancer, epilepsy, Parkinson's disease, etc. We included a dietary intake
questionnaire in the general health and risk factors record. We measured systolic and diastolic
blood pressure, height, weight and waist circumference for all participants according to stan-
dard procedures. [20] The GMS questionnaire data were analysed by a computer program-
assisted diagnosis, the Automated Geriatric Examination for Computer Assisted Taxonomy
(AGECAT), to assess the principal mental disorders in the study participants. [18]
In the interview, we asked each participant for details of hypercholestoralemia. Participants
with hypercholesterolemia were those who gave a positive answer to “Do you have a doctor-
diagnosed hypercholesterolemia?”. If yes, they were asked how many years they had hypercho-
lesterolemia and whether they took any lowering-lipids medication. We defined ‘untreated
hypercholesterolemia’ as those who gave negative answers to the last enquiry.
Statistical analysis
The SPSS statistical package (Windows version 21.0; SPSS Inc, Chicago, Ill) was used for data
analysis. Patient characteristics comparing treated and untreated using lipid-lowering
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medications were tested by chi-square test. Using a logistic regression model we calculated
odds ratios (ORs) and 95% confidence intervals (CIs) for untreated hypercholesterolemia in
relation to individual characteristics, adjusted for age, sex and duration of hypercholesterol-
emia. Previous studies showed that age and sex were associated with taking lowering-lipid
medications. [8, 9] In China, some older adults would not like to take medications immediately
following the diagnosis of a chronic condition, which is not acute and serious. However in time
they will eventually take medications for treatment. The time since hypercholesterolemia diag-
nosis would be also associated with other variables such as the consumption of meat and CHD.
Therefore we took these 3 variables for adjustment in an initial logistic regression analysis. We
employed a multivariate logistic model, which included urban-rural living and all variables
with a p value< = 0.1 in the above adjustment analysis, to assess the correlates for untreated
hypercholesterolemia. We carried out a sensitivity analysis in participants who did not have
chronic kidney disease (CKD) as the CKD may prevent from using lipid-lowering medications
due to its metabolic issues. In the multivariate analysis we further used a stepwise method (for-
ward: Wald) in the logistic model to examine the correlates.
Results
Of 7,572 participants, 328 (4.3%) were reported to have doctor-diagnosed hypercholesterol-
emia. Of these with hypercholesterolemia, the average age was 71.4 years (SD 7.1) with a range
of 60–93, and 60.1% were women. They are not significantly different from those who were not
reported to have hypercholesterolemia (age 72.0 (7.7), 54.9% women). However, they were
more likely to have higher levels of education (> = high secondary school 34.1% versus 12.2%)
and family income (RMB Yuan 17242 versus 11150), live in an urban area (79.6% versus
42.6%) and have a larger body mass index (BMI at 24.2 versus 22.8).
Among 328 participants with hypercholesterolemia (S1 Dataset included in Supporting
Information), 209 were not treated (63.7% (95% CI 58.5%-68.9%)). The odds ratios for receipt
of treatment for hypercholesterolemia stratified by individual characteristics in older Chinese
adults are depicted in Table 1. Compared to those with treated hypercholesterolemia, patients
who were untreated were more like to be current smokers, heavy alcohol drinkers, consume
more meat, and have a shorter duration (<3years) of diagnosed hypercholesterolemia.
Untreated hypercholesterolemia was inversely associated with coronary heart disease, but it
was not significantly associated with other cardiovascular disease and risk factors in Table 1.
Table 2 shows ORs for the correlates of untreated hypercholesterolemia in a multivariate
analysis. Being untreated was significantly associated with being female, current smoking,
heavy alcohol drinking and more consumption of meat, and inversely with CHD. The associa-
tion with chronic bronchitis was borderline significant. In the sensitivity analysis after exclud-
ing participants with chronic kidney disease, the findings of the associations were similar to
those in the data analysis of all participants, but less significant probably due to a smaller num-
ber of participants.
In the stepwise regression analysis for all patients, the final-step results showed that being
untreated was associated with female sex, current smoking, heavy alcohol drinking, CHD,
chronic bronchitis and more consumption of meat (Table 3).
Discussion
In this community-based health survey of older adults in China we found that about two-thirds
of patients who had self-reported doctor-diagnosed hypercholesterolemia were not on lipid-
lowering medication. Untreated hypercholesterolemia was associated with female sex, current-
smoking, heavy alcohol drinking, chronic bronchitis, and more consumption of meat.
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Table 1. Characteristics of participants with hypercholesterolemia: frequencies and odds ratios for receipt of treatment for hypercholesterolemia
in older adults.
Treated Untreated Odds ratio adjusted for age,
sex and duration of
hypercholesterolemia
Variable n = 119 % n = 209 % Chi-square
test p
OR† 95%CI P*
Basic characteristics
Age (years)
60~64 28 23.5 44 21.1 0.060 1.11 (0.60–2.06)
65~74 42 35.3 101 48.3 1.75 (1.03–2.96) @1
75 49 41.2 64 30.6 1.00 0.089
Sex
Men 52 43.7 79 37.8 1.00 0.495
Women 67 56.3 130 62.2 0.294 1.18 (0.74–1.89)
Body mass index (kg/m2)
< 25 80 68.4 131 63.6 0.685 1.00 0.717
25–30 28 23.9 57 27.7 1.24 (0.72–2.13)
30 9 7.7 18 8.7 1.19 (0.50–2.83)
Socio-economic status
Educational level
> = High Secondary Sch. 40 33.6 72 34.4 0.291 1.00 0.369
Secondary school 30 25.2 38 18.2 0.68 (0.36–1.29)
< = Primary Sch. 49 41.2 99 47.4 1.04 (0.61–1.78)
Main occupation
Ofﬁcial/teacher 46 38.7 65 31.1 0.117 1.00 0.268
Businessmen, housewives and other 15 12.6 44 21.1 1.82 (0.87–3.83)
manual labour or Peasant 58 48.7 100 47.8 1.11 (0.66–1.87)
Annual personal income (RMB, Yuan)
20000 44 37.0 82 39.2 0.750 1.00 0.438
10000-<20000 54 45.4 86 41.1 0.70 (0.41–1.21)
<10000 21 17.6 41 19.6 0.86 (0.44–1.70)
Averaged income of family member per year (RMB, Yuan)
20000 38 31.9 66 31.6 0.982 1.00 0.867
10000-<20000 57 47.9 99 47.4 0.88 (0.52–1.51)
<10000 24 20.2 44 21.1 0.85 (0.43–1.67)
Urban-rurality
Urban 99 83.2 162 77.5 0.220 1.00 0.334
Rural 20 16.8 47 22.5 1.35 (0.73–2.49)
Lifestyles
Smoking status
Never 91 76.5 146 69.9 0.037 1.00 0.017
Former 18 15.1 24 11.5 1.21 (0.55–2.62)
Current 10 8.4 39 18.7 3.27 (1.43–7.44) @2
Alcohol drinking/ month
No 108 90.8 175 83.7 0.118 1.00 0.050
1–9 times 5 4.2 9 4.3 1.43 (0.45–4.62)
10–90 times 6 5.0 25 12.0 3.32 (1.26–8.77) @1
Favourite salt level in dishes
(Continued)
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Table 1. (Continued)
Treated Untreated Odds ratio adjusted for age,
sex and duration of
hypercholesterolemia
Variable n = 119 % n = 209 % Chi-square
test p
OR† 95%CI P*
Light 52 43.7 98 46.9 0.855 1.00 0.906
Middle 42 35.3 70 33.5 0.89 (0.53–1.50)
Heavy 25 21.0 41 19.6 0.98 (0.53–1.83)
Consumption of meat in recent 2 years
< Once a week 21 17.6 15 7.2 0.019 1.00 0.015
Once a week 39 32.8 64 30.6 2.67 (1.20–5.94) @1
> = Twice a week and < = once a day 30 25.2 71 34.0 3.61 (1.61–8.08) @2
> = Twice a day 29 24.4 59 28.2 3.15 (1.38–7.16) @2
Consumption of ﬁsh in recent 2 years
< Once a week 20 16.8 31 14.8 0.142 1.00 0.146
Once a week 46 38.7 68 32.5 0.91 (0.45–1.82)
> = Twice a week and < = once a day 28 23.5 75 35.9 1.69 (0.82–3.49)
> = Twice a day 25 21.0 35 16.7 0.88 (0.40–1.92)
Consumption of egg in recent 2 years
< Once a week 11 9.2 25 12.0 0.272 1.00 0.297
Once a week 29 24.4 39 18.7 0.63 (0.26–1.50)
> = Twice a week and < = once a day 28 23.5 66 31.6 1.15 (0.49–2.72)
> = Twice a day 51 42.9 79 37.8 0.76 (0.34–1.73)
Consumption of vegetables in recent 2 years
< Once a day 5 4.2 12 5.7 0.749 1.00 0.569
Once a day 54 45.4 88 42.1 0.57 (0.18–1.74)
> = Twice a day 60 50.4 109 52.2 0.65 (0.21–1.99)
Consumption of fruits in recent 2 years
< Once a day 57 47.9 90 43.1 0.693 1.00 0.726
Once a day 51 42.9 97 46.4 1.16 (0.71–1.88)
> = Twice a day 11 9.2 22 10.5 1.34 (0.59–3.04)
Do regular exercise
No 75 63.0 125 59.8 0.566 1.00 0.597
Yes 44 37.0 84 40.2 1.14 (0.71–1.83)
Walk often
No 22 18.5 42 20.1 0.724 1.00 0.661
Yes 97 81.5 167 79.9 0.88 (0.49–1.57)
Social network and support
Religious belief
No 94 79.0 171 81.8 0.532 1.00 0.226
Yes 25 21.0 38 18.2 0.69 (0.38–1.26)
Marital status
Married 87 73.1 164 78.5 0.528 1.00
Widow 29 24.4 40 19.1 0.72 (0.40–1.28) 0.525
Divorced/never married 3 2.5 5 2.4 1.00 (0.22–4.49)
Living condition
Live alone 17 14.3 23 11.0 0.383 1.00 0.423
Live with somebody 102 85.7 186 89.0 1.33 (0.66–2.65)
(Continued)
Correlates of Untreated Hypercholesterolemia in Older Adults
PLOS ONE | DOI:10.1371/journal.pone.0131318 July 10, 2015 6 / 13
Table 1. (Continued)
Treated Untreated Odds ratio adjusted for age,
sex and duration of
hypercholesterolemia
Variable n = 119 % n = 209 % Chi-square
test p
OR† 95%CI P*
Number of children
0–1 20 16.8 25 12.0 0.367 1.00 0.332
2–3 64 53.8 111 53.1 1.21 (0.61–2.42)
4 35 29.4 73 34.9 1.67 (0.80–3.51)
Frequency of visiting children/relatives
Daily 26 21.8 37 17.7 0.618 1.00 0.715
<Daily and  Monthly 46 38.7 89 42.6 1.29 (0.68–2.44)
< monthly 47 39.5 83 39.7 1.25 (0.66–2.36)
Help available when needed
No 9 7.6 22 10.5 0.378 1.00 0.398
Yes 110 92.4 187 89.5 0.70 (0.30–1.61)
Health status and disease histories
Perception of self-health
Good 54 45.4 91 43.5 0.061 1.70 (0.78–3.70)
Average 47 39.5 102 48.8 2.35 (1.08–5.11) @1
Poor 18 15.1 16 7.7 1.00 0.080
Duration of hypercholestrolimia (years)
<3 years 26 21.8 64 30.6 0.087 1.89 (1.01–3.52) @1
3-<10 years 52 43.7 94 45.0 1.41 (0.81–2.45)
> = 10 years 41 34.5 51 24.4 1.00 0.132
Hypertension (BP> = 140/90 mm Hg or taking anti-
hytpertensive medication)
No 25 21.0 53 25.4 0.374 1.00 0.410
Yes 94 79.0 156 74.6 0.79 (0.45–1.38)
Coronary heart disease
No 79 66.4 167 79.9 0.007 1.00 0.010
Yes 40 33.6 42 20.1 0.51 (0.30–0.85) @2
Stroke
No 107 89.9 186 89.0 0.795 1.00 0.534
Yes 12 10.1 23 11.0 1.28 (0.59–2.76)
Diabetes
No 86 72.3 169 80.9 0.072 1.00 0.102
Yes 33 27.7 40 19.1 0.64 (0.37–1.09)
Chronic kidney disease (CKD)
No 107 184 89.9 88.0 0.605 1.00 0.659
Yes 12 25 10.1 12.0 1.19 (0.56–2.52)
Chronic bronchitis
No 106 89.1 169 80.9 0.052 1.00 0.094
Yes 13 10.9 40 19.1 1.81 (0.90–3.61) @
Vision problems
No 73 61.3 110 52.6 0.127 1.00 0.115
Yes 46 38.7 99 47.4 1.46 (0.91–2.33)
Hearing problems
(Continued)
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Strengths and weakness of study
Our study is the first to report correlates of untreated hypercholesterolemia in older adults in
China. The studied participants are derived from a multi-province community-based survey
and thus the data reflects ‘real-world’ older population. Our study investigated dietary intake
factors and physical activities which were not investigated in previous studies. [7] [8] [9] When
we examined correlates of untreated hypercholesterolemia, we carried out a sensitivity analysis
by excluding participants with chronic kidney disease, a contra-indication to most lowering-
lipid medications. Our study is cross-sectional, and thus the causal-result relationships between
correlate factors and untreatment require a large-scale cohort study to confirm. We do not
have data on serum cholesterol from each patient as the hypercholesterolemia is self reported
doctor-diagnosed and this may lead to an underestimate of the prevalence of hypercholesterol-
emia. A previous national survey in China used a cut-off point of> = 5.72 mmol/L in serum
total cholesterol level to produce a 6.1% prevalence of hypercholesterolemia in older adults
aged 60 years or over. [21] Its prevalence rate would be closer to our study with its 4.3%, if a
cut-off point of> = 6.22 mmol/L were used to define hypercholesterolemia according to the
Chinese guidelines for management. [22] We acknowledge that participants with undetected
hypercholesterolemia were mostly from lower socioeconomic groups, perhaps as they were less
likely to undergo routine health screening, thus potentially resulting in the lack of association
we note between socioeconomic deprivation and being untreated. However, missing such par-
ticipants would not attenuate the significant associations we observe between untreated hyper-
cholesterolemia and other individual characteristics in the analysis. Without data of serum
cholesterol level from each patient we were unable to investigate whether the patients with very
high hypercholesterolemia took medicines while and those with moderate to low levels of
Table 1. (Continued)
Treated Untreated Odds ratio adjusted for age,
sex and duration of
hypercholesterolemia
Variable n = 119 % n = 209 % Chi-square
test p
OR† 95%CI P*
No 95 79.8 158 75.6 0.380 1.00 0.390
Yes 24 20.2 51 24.4 1.28 (0.73–2.25)
Depression‡
No 102 85.7 184 88.0 0.751 1.00 0.726
Subcase 5 4.2 9 4.3 0.99 (0.31–3.12)
Case 12 10.1 16 7.7 0.72 (0.32–1.61)
Dementia‡
No 113 95.0 193 92.3 0.363 1.00 0.406
Subcase/Case 6 5.0 16 7.7 1.52 (0.56–4.13)
† adjusted for age, sex and duration of hypercholesterolemia (model 1).
‡diagnosed by the GMS-AGECAT.
*overall p value for each whole factor.
@ p< = 0.100 and >0.05
@1 p< = 0.05 and >0.01
@2 p< = 0.01 and >0.001
@3 p< = 0.001
doi:10.1371/journal.pone.0131318.t001
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Table 2. Multivariate logistic regression† to determine factors associated with untreated hypercholesterolemia in older adults.
All participants Participants without CKD
Variable OR 95%CI P* OR 95%CI P*
Age (years)
60~64 1.11 (0.55–2.24) 1.07 (0.51–2.22)
65~74 1.67 (0.94–2.97) 1.63 (0.89–2.98)
75 1.00 0.183 1.00 0.242
Sex
Men 1.00 0.039 1.00
Women 1.92 (1.03–3.58) @1 2.01 (1.03–3.90) @1 0.041
Urban-rurality
urban 1.00 0.530 1.00
Rural 1.25 (0.62–2.53) 1.24 (0.61–2.52) 0.557
Smoking status
Never 1.00 0.055 1.00 0.127
Former 1.22 (0.52–2.83) 1.06 (0.44–2.54)
Current 3.05 (1.22–7.59) @1 2.54 (1.00–6.42) @1
Alcohol drinking per month
No 1.00 0.040 1.00 0.051
1–9 times 0.62 (0.16–2.34) 0.69 (0.18–2.73)
10–90 times 3.58 (1.22–10.47) @1 3.61 (1.20–10.80) @1
Self-feeling health status
Good/very good 1.32 (0.57–3.04) 1.55 (0.62–3.85)
Average 1.88 (0.81–4.36) 2.05 (0.82–5.16) @
Poor 1.00 0.235 1.00 0.273
Duration of hypercholestrolimia (years)
<3 years 1.80 (0.90–3.58) @ 1.82 (0.88–3.76) @
3-<10 years 1.28 (0.69–2.36) 1.51 (0.78–2.91)
> = 10 years 1.00 0.247 1.00 0.250
Diabetic
No 1.00 0.327 1.00 0.279
Yes 0.74 (0.41–1.34) 0.70 (0.37–1.33)
Coronary heart disease
No 1.00 0.007 1.00 0.023
Yes 0.46 (0.26–0.81) @2 0.48 (0.26–0.91) @1
Chronic bronchitis
No 1.00 0.083 1.00 0.058
Yes 1.95 (0.92–4.15) @ 2.21 (0.98–5.00) @
Meat
< Once a week 1.00 0.027 1.00 0.111
Once a week 2.29 (0.96–5.43) @ 1.98 (0.81–4.85)
> = Twice a week and < = once a day 3.65 (1.53–8.73) @2 2.96 (1.21–7.26) @1
> = Twice a day 2.97 (1.22–7.22) @1 2.45 (0.96–6.23) @
† including the variables in model 1, factors with p value <0.10 in Table 1, and variables of urban-rurality and diabetes.
*overall p value for each whole factor.
@ p< = 0.100 and >0.05
@1 p< = 0.05 and >0.01
@2 p< = 0.01 and >0.001
@3 p< = 0.001
doi:10.1371/journal.pone.0131318.t002
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hypercholesterolemia did not. Further research on determinants of untreated hypercholesterol-
emia in older adults is required.
Data from the World Health Orgnisation (WHO) showed that in China about 230 million
people have cardiovascular disease and one in five adult Chinese have a cardiovascular disease.
[23] Cardiovascular disease has been listed as one of top priority in China National Plan for
NCD Prevention and Treatment (2012–2015).[23] High cholesterol is one of the main risk fac-
tors for cardiovascular disease leading to coronary heart disease, stroke and death. In 2007,
before our survey started, the Chinese guidelines for prevention and treatment for hypercholes-
terolemia in adults was published[24] and stated that since the clinical benefits of lowering lip-
ids on CHD incidence are seen for all ages of participants, treatment of hypercholesterolemia
in older adults is indicated, and moreover there are no contraindications of the medication
treatment. With the higher co-morbidity in older people such as a decline in renal function,
however such treatment needs to be personalised and the initial dosage should start low. [24]
Apart from lipid-lowering medications, dietary intake control and physical activity also lower
lipid levels. However, in the current study there is no evidence that not being on lipid-lowering
medications was accounted for by dietary intake control and physical activity. In contrast, not
Table 3. Stepwise logistic regression† to determine factors associated with untreated hypercholester-
olemia in older adults.
Variable OR 95%CI P*
Sex
Men 1.00 0.014
Women 2.13 (1.17–3.89) @1
Smoking status
Never 1.00 0.019
Former 1.17 (0.51–2.67)
Current 3.48 (1.44–8.44) @2
Alcohol drinking per month
No 1.00 0.054
1–9 times 0.58 (0.16–2.10)
10–90 times 3.13 (1.11–8.84) @1
Coronary heart disease
No 1.00 0.002
Yes 0.41 (0.24–0.72) @2
Chronic bronchitis
No 1.00 0.020
Yes 2.37 (1.14–4.90) @1
Meat
< Once a week 1.00 0.021
Once a week 2.21 (0.98–4.99)
> = Twice a week and < = once a day 3.61 (1.57–8.31) @2
> = Twice a day 2.85 (1.22–6.65) @1
† all variables selected in the analysis were the same as those in Table 2.
*overall p value for each whole factor.
@ p< = 0.100 and >0.05
@1 p< = 0.05 and >0.01
@2 p< = 0.01 and >0.001
@3 p< = 0.001
doi:10.1371/journal.pone.0131318.t003
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being on lipid-lowering medication among hypercholesterolemia participants was significantly
associated with smoking, which is consistent with the findings in previous studies in high
income countries.[8] A more interesting finding was that those with untreated hypercholester-
olemia had higher levels of alcohol drinking and meat consumption than treated participants.
Thus there was no evidence that being untreated was due to other lifestyle interventions for
controlling hypercholesterolemia, known to be effective in wider populations. [14]
We did not find that women with hypercholesterolemia had less treatment in the initial
analysis. However, in the multivariate analysis including the smoking variable, being untreated
was significantly associated with female sex as Chinese women rarely smoke. Sex inequality in
treatment has also been found in other studies; in secondary prevention, women had less treat-
ment than men. [9] Our data showed that women with hypercholesterolemia received less
treatment than men. This would suggest an important inequality in health care as we found
previously in mental health. [15] That hypercholesterolemia participants with chronic bronchi-
tis had double the odds of not being treated with lipid-lowering medication may reflect a poly-
pharmacy issue here, as participants may find it would be hard to cope with multiple
medicines.
In this study we observed that more than half of those participants with CHD (51.2%),
stroke (65.7%), hypertension (62.4%) or diabetes (54.8%) were not treated using lowering lipid
medications (Table 1). Although the finding of a significant association between CHD and
treatment for hypercholesterolemia is consistent with those in previous studies, [7] it should be
noted that only about half of CHD patients had treated hypercholesterolemia in China. This is
much lower than that in high income countries, e.g., 79% of CHD patients were on lipid-lowing
medications in the EUROASPIRE III study.[25] Our data further showed that the proportions
of participants with hypertension, diabetes and stroke who took lipid-lowing medications were
significantly lower than the participants in high income countries.[5,26] These findings high-
light that there is lack of awareness of major aetiologic and prognostic factors of cardiovascular
disease, and the importance of secondary drug prevention for public health in China.
The low proportion of participants who were on lipid-lowing therapy could be also
explained by their belief about the condition and medicines. Most Chinese people feel hyper-
cholesterolemia is not a serious condition because there are no physical symptoms associated
with this condition and thus complications may not occur. Furthermore, there is a common
perception in the general population in China, particularly amongst older people, that any
medicine has a side effect or toxicity, perhaps in part due to stories about the side-effects in
Chinese medicine. [27,28] For instance some Chinese consider that in older people, treatment
using mediation is not merited because of a perceived lack of prognostic benefit and increased
side effects. Therefore participants with hypercholesterolemia are more likely not to take medi-
cine or take it intermittently until the disease progresses and complications appear. This may
explain the finding that those with a good perception of self-health may have an increased risk
of being untreated for hypercholesterolemia. Further study into health behaviour and belief
about medicines would help to ascertain whether behaviour and belief play important roles in
patient acceptance of chronic disease medication management. A health promotion program
to manage these risk factors for cardiovascular disease and secondary prevention is perhaps
part of the plan needed to tackle this growing public health problem.
In conclusion,more than two-thirds of older adults with hypercholesterolemia were not on
lipid-lowering medication in China. Being untreated was positively related to being female,
current smoking, heavy alcohol drinking, more consumption of meat, and chronic bronchitis.
These participants with co-morbidities of coronary heart disease, stroke, hypertension or dia-
betes were given less treatment for hypercholesterolemia compared to those in high income
countries. Qualitative research is needed to better understand why this occurs–from doctors,
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patients and carers. Our research findings highlight a pressing need to tackle untreated hyper-
cholesterolemia in older adults with hypercholesterolemia.
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